Endometrial Cancer Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Condition (Endometrioid Carcinoma, Serous Adenocarcinoma, Adenosquamous Carcinoma, Carcinomasarcoma), By Test (Hysteroscopy, Endometrial Biopsy, Dilation and Curettage, Ultrasound, CT Scan, MRI), By End-user (Diagnostic Centers, Hospitals, Ambulatory Surgical Centers) and Region Forecast 2019-2030  

Endometrial Cancer Diagnostics Market size was valued at US$ 22.4 billion in 2023 and estimated to reach at US$ 29.4 billion by 2030, growing at a significant CAGR of 5.4% From 2024-2030. Endometrial Cancer is the most common form of uterine cancer as the endometrium is part of the uterus. Endometrial cancer is often called uterine cancer. It is the most commonly diagnosed gynecologic cancer. Endometrial cancer forms when cells in the inner lining of the uterus (endometrium) begin to grow out of control. Unlike breast and prostate cancer where screening tests are available to the general population endometrial cancer is most commonly diagnosed at endometrial biopsy in symptomatic patients. No generally applicable screening test is available. Among all test types hysteroscopy is most commonly recommended uterine cancer diagnostic test.

According to the American Cancer Society, in 2017, about 61380 new cases of uterine cancer were diagnosed and around 10,000 were dead. According to WHO, developed regions such as North America and Europe registers greater incidence rate for endometrial cancer due to lifestyle changes adopted by women. Women with abnormal vaginal bleeding are detected with endometrial cancer at an early stage. Endometrial cancer is the sixth most common cancer in women worldwide, according to statistics. Because of the increased prevalence of market is predicted to grow significantly. Other key factors contributing to the market's growth include rising female obesity, increased menopausal hormone therapy, changes in sedentary lifestyle, socioeconomic factors, rising consumption of unhealthy diet, rising occurrence of Polycystic Ovarian Syndrome (PCOS), and rising prevalence of breast or ovarian tumour. Another condition that contributes to the development of endometrial cancer is diabetes. Endometrial cancer is four times more likely in diabetes women than in non-diabetic women, according to the American Cancer Society. Endometrial cancer is caused by such factors in women.